Bank Hapoalim BM’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39M | Sell |
11,519
-765
| -6% | -$88.3K | 0.21% | 60 |
|
|
2025
Q4 | $1.29M | Buy |
12,284
+30
| +0.2% | +$2.82K | 0.11% | 66 |
|
|
2025
Q3 | $1.03M | Sell |
12,254
-10,100
| -45% | -$832K | 0.13% | 72 |
|
|
2025
Q2 | $1.77M | Sell |
22,354
-4,400
| -16% | -$350K | 0.24% | 62 |
|
|
2025
Q1 | $2.4M | Buy |
26,754
+6,420
| +32% | +$599K | 0.35% | 49 |
|
|
2024
Q4 | $2.02M | Sell |
20,334
-1,840
| -8% | -$190K | 0.33% | 58 |
|
|
2024
Q3 | $2.52M | Sell |
22,174
-470
| -2% | -$55.8K | 0.38% | 53 |
|
|
2024
Q2 | $2.8M | Buy |
22,644
+50
| +0.2% | +$6.44K | 0.4% | 54 |
|
|
2024
Q1 | $2.98M | Buy |
22,594
+370
| +2% | +$45.6K | 0.39% | 56 |
|
|
2023
Q4 | $2.42M | Sell |
22,224
-425
| -2% | -$44.1K | 0.33% | 62 |
|
|
2023
Q3 | $2.33M | Sell |
22,649
-706
| -3% | -$76.1K | 0.38% | 60 |
|
|
2023
Q2 | $2.69M | Sell |
23,355
-150
| -0.6% | -$17K | 0.38% | 60 |
|
|
2023
Q1 | $2.5M | Sell |
23,505
-2,400
| -9% | -$259K | 0.35% | 62 |
|
|
2022
Q4 | $2.87M | Sell |
25,905
-561
| -2% | -$57.3K | 0.36% | 62 |
|
|
2022
Q3 | $2.28M | Hold |
26,466
| – | – | 0.29% | 70 |
|
|
2022
Q2 | $2.41M | Sell |
26,466
-265
| -1% | -$23.5K | 0.3% | 74 |
|
|
2022
Q1 | $2.19M | Buy |
26,731
+1,570
| +6% | +$124K | 0.23% | 85 |
|
|
2021
Q4 | $1.93M | Buy |
25,161
+3,896
| +18% | +$310K | 0.19% | 90 |
|
|
2021
Q3 | $1.6M | Buy |
21,265
+1,594
| +8% | +$121K | 0.17% | 97 |
|
|
2021
Q2 | $1.53M | Sell |
19,671
-76
| -0.4% | -$5.65K | 0.17% | 102 |
|
|
2021
Q1 | $1.45M | Buy |
19,747
+2,164
| +12% | +$160K | 0.18% | 99 |
|
|
2020
Q4 | $1.37M | Buy |
17,583
+2,597
| +17% | +$199K | 0.19% | 85 |
|
|
2020
Q3 | $1.19K | Sell |
14,986
-472
| -3% | -$37K | 0.06% | 77 |
|
|
2020
Q2 | $1.14M | Hold |
15,458
| – | – | 0.27% | 70 |
|
|
2020
Q1 | $1.14M | Hold |
15,458
| – | – | 0.36% | 62 |
|
|
2019
Q4 | $1.34M | Sell |
15,458
-1,258
| -8% | -$103K | 0.29% | 66 |
|
|
2019
Q3 | $1.32M | Sell |
16,716
-2,724
| -14% | -$218K | 0.32% | 59 |
|
|
2019
Q2 | $1.55M | Hold |
19,440
| – | – | 0.38% | 53 |
|
|
2019
Q1 | $1.54M | Sell |
19,440
-509
| -3% | -$38.1K | 0.37% | 53 |
|
|
2018
Q4 | $1.45M | Sell |
19,949
-157
| -0.8% | -$11.1K | 0.47% | 50 |
|
|
2018
Q3 | $1.36M | Hold |
20,106
| – | – | 0.33% | 65 |
|
|
2018
Q2 | $1.17M | Buy |
20,106
+6,938
| +53% | +$391K | 0.32% | 65 |
|
|
2018
Q1 | $684K | Buy |
13,168
+1,079
| +9% | +$58.3K | 0.18% | 101 |
|
|
2017
Q4 | $649 | Buy |
12,089
+1,897
| +19% | +$105K | 0.14% | 113 |
|
|
2017
Q3 | $623K | Buy |
10,192
+3,977
| +64% | +$241K | 0.14% | 124 |
|
|
2017
Q2 | $380K | Sell |
6,215
-560
| -8% | -$34.1K | 0.09% | 149 |
|
|
2017
Q1 | $411K | Buy |
+6,775
| New | +$411K | 0.1% | 137 |
|
|
2015
Q2 | – | Sell |
-7,430
| Closed | -$1.23M | – | 185 |
|
|
2015
Q1 | $1.23M | Buy |
7,430
+5,145
| +225% | +$291K | 0.22% | 76 |
|
|
2014
Q4 | $124K | Buy |
+2,285
| New | +$127K | 0.03% | 157 |
|
Other funds holding MRK
VCM
VPM
Bank Hapoalim BM's MRK Position: Q1 2026 in Review
Bank Hapoalim BM reduced its Merck (MRK) stake by 6.2% in Q1 2026, selling an estimated $88.3K and leaving 11,519 shares worth $1.39M. The position accounts for 0.21% of the portfolio, ranked #60.
Bank Hapoalim BM first reported a position in MRK in Q4 2014 and has held it in 39 quarters since. The position peaked at $2.98M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bank Hapoalim BM held 11,519 shares of Merck worth $1.39M as of Q1 2026.
- Bank Hapoalim BM sold 765 Merck shares in Q1 2026, an estimated $88.3K.
- Merck made up 0.21% of Bank Hapoalim BM's portfolio in Q1 2026, its #60 holding.
- Bank Hapoalim BM first reported a position in Merck in Q4 2014 and has held it in 39 quarters since.
- Bank Hapoalim BM's Merck position peaked at $2.98M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bank Hapoalim BM's 13F filing for Q1 2026, filed 4 May 2026.